Mesenchymal stem cells and their challenges for bone regeneration and osseointegration

Journal of Periodontology

Volumn 83, Issue 5, 2012, Pages 547-550

  Razzouk, Sleiman ^a   Schoor, Robert ^a  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

Bone regeneration; Dental implants; Mesenchymal stem cells; Mesenchymal stromal cells

Indexed keywords

AGE; ALVEOLAR BONE LOSS; BONE REGENERATION; CELL AGING; CULTURE MEDIUM; CULTURE TECHNIQUE; GENOMIC INSTABILITY; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; REVIEW; TOOTH IMPLANT;

AGE FACTORS; ALVEOLAR BONE LOSS; BONE REGENERATION; CELL AGING; CELL CULTURE TECHNIQUES; CULTURE MEDIA; DENTAL IMPLANTS; GENOMIC INSTABILITY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; OSSEOINTEGRATION;

EID: 84860469460     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110384     Document Type: Review

References (36)

1. Rastegar F, Shenaq D, Huang J, et al. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells 2010;2:67-80.
2. Beyth S, Schroeder J, Liebergall M. Stem cells in bone diseases: Current clinical practice. Br Med Bull. 2011;99:199-210.
3. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
4. Phinney DG, Prockop DJ. Concise review: Mesenchy-mal stem/multipotent stromal cells: The state of trans-differentiation and modes of tissue repair\Current views. Stem Cells 2007;25:2896-2902. (Pubitemid 350127874)
5. Caimi PF, Reese J, Lee Z, Lazarus HM. Emerging therapeutic approaches for multipotent mesenchymal stromal cells. Curr Opin Hematol 2010;17:505-513.
6. Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 2010;21:1513-1526.
7. Caplan AI. Why are MSCs therapeutic? New data: New insight. J Pathol 2009;217:318-324.
8. Gandia C, Armiñan A, Garćia-Verdugo JM, et al. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells 2008;26:638-645.
9. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: Their biology and role in regenerative medicine. J Dent Res 2009;88:792-806.
10. Hunt CJ. Cryopreservation of human stem cells for clinical application: A review. Transfus Med Hemother 2011;38:107-123.
11. Mendoncxa JJ, Juiz-Lopez P. Regenerative facial reconstruction of terminal stage osteoradionecrosis and other advanced craniofacial diseases with adult cultured stem and progenitor cells. Plast Reconstr Surg 2010;126:1699-1709.
12. Runyan CM, Taylor JA. Clinical applications of stem cells in craniofacial surgery. Facial Plast Surg 2010;26:385-395.
13. Ward BB, Brown SE, Krebsbach PH. Bioengineering strategies for regeneration of craniofacial bone: A review of emerging technologies. Oral Dis 2010;16: 709-716.
14. Gonshor A, McAllister BS, Wallace SS, Prasad H. Histologic and histomorphometric evaluation of an allograft stem cell-based matrix sinus augmentation procedure. Int J Oral Maxillofac Implants 2011;26: 123-131.
15. McAllister BS, Haghighat K, Gonshor A. Histologic evaluation of a stem cell-based sinus-augmentation procedure. J Periodontol 2009;80:679-686.
16. Ueda M, Yamada Y, Ozawa R, Okazaki Y. Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement. Int J Periodontics Restorative Dent 2005;25: 129-137. (Pubitemid 40461508)
17. McAllister BS. Stem cell-containing allograft matrix enhances periodontal regeneration: Case presentations. Int J Periodontics Restorative Dent 2011;31: 149-155.
18. Park JB. Use of cell-based approaches in maxillary sinus augmentation procedures. J Craniofac Surg 2010;21:557-560.
19. Bueno EM, Glowacki J. Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol 2009;5:685-697.
20. Fedorovich NE, Alblas J, Hennink WE, Oner FC, Dhert WJ. Organ printing: The future of bone regeneration? [published online ahead of print, August 8, 2011] Trends Biotecnhol. doi:10.1016/j.tibtech.2011.07.001.
21. Sensebé L, Bourin P, Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 2011;22:19-26.
22. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mes-enchymal stem cells: Consequences for cell therapies. Mech Ageing Dev 2008;129:163-173.
23. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999;14:1115-1122. (Pubitemid 29314054)
24. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919-926. (Pubitemid 37543568)
25. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007;25:1384-1392. (Pubitemid 47106005)
26. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147. (Pubitemid 29282067)
27. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005;87: 1430-1437. (Pubitemid 40917741)
28. McLain RF, Fleming JE, Boehm CA, Muschler GF. Aspiration of osteoprogenitor cells for augmenting spinal fusion: Comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 2005;87:2655-2661. (Pubitemid 41747032)
29. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 2000;28:707-715. (Pubitemid 30398528)
30. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchy-mal stem cell in vitro. BMC Cell Biol 2006;7:14.
31. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004;22:675-682. (Pubitemid 39172200)
32. Wagner W, Ho AD, Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 2010;16:445-453.
33. Boquest AC, Shahdadfar A, Frønsdal K, et al. Isolation and transcription profiling of purified uncultured human stromal stem cells: Alteration of gene expression after in vitro cell culture. Mol Biol Cell 2005;16:1131-1141. (Pubitemid 40349551)
34. Dahl JA, Duggal S, Coulston N, et al. Genetic and epigenetic instability of human bone marrow mesen-chymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol 2008;52:1033-1042.
35. Rosland GV, Svendsen A, Torsvik A, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 2009;13:5331-5339.
36. Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67:9142-9149. (Pubitemid 47535900)